MINISTRY OF ECONOMY: FIRST ISRAELI DELEGATION AS PART OF BILATERAL R&D
AGREEMENT WITH JAPAN OFF TO TOKYO AT END OF MONTH, LED BY OFFICE OF CHIEF
SCIENTIST AND FOREIGN TRADE ADMINISTRATION IN ISRAEL MINISTRY OF ECONOMY

JERUSALEM, ISRAEL. JULY 27th 2015 – The first Israeli business delegation
will arrive tomorrow - Tuesday (July 28TH, 2015) in Tokyo as part of an
agreement on R&D cooperation signed between Israel and Japan. The delegation
will include representatives of Israeli life sciences firms, including
companies in the fields of pharma, medical equipment, agro-biotech,
diagnostics and health IT.

Israeli Minister of Economy, Aryeh Machluf Deri, said: "Developing Israel's
economic ties with Japan and cooperation in the areas of science, technology
and commerce are important in view of Japan’s significance and its regional
status. This growing cooperation will enable Israeli companies to be exposed
to new markets and to develop in the region."

The cooperation agreement signed between the governments of Israel and Japan
enables parallel support of joint R&D projects and helps Israeli and
Japanese companies find R&D partners. The agreement is being implemented by
the Office of the Chief Scientist at the Israeli Ministry of Economy.

The delegation was jointly organized by the Office of the Chief Scientist at
the Israeli Ministry of Economy, The Israeli Industry Center of Research and
Development (MATIMOP) and the New Energy and Industrial Technology
Development Organization (NEDO) at the Japanese Ministry of Economy, Trade
and Industry (METI). The delegation will be led by the Chief Scientist at
the Israeli Ministry of Economy, Avi Hasson.

As part of the delegation's itinerary, Israeli representatives will visit
several major players in Japanese industry, including major medical
companies. In addition, the representatives will take part in a seminar on
Japanese regulations related to pharmaceuticals and medical devices and in a
networking event which will include presentations and B2B meetings with
Japanese companies.

Members of the delegation will learn about the Japanese bio-tech market and
about the extensive routes for investment, cooperation, and other business
opportunities which will also help Japanese companies with business
development.

Among the Israeli companies represented in the delegation, are: AB Dental
Devices Ltd., Can-Fite BioPharma, Emerald Medical Applications, EyeYon
Medical, Kamada, Moebius Medical Ltd., NeviMed, NovellusDx, Pluristem,
PolyPid Ltd., STI Laser Industries, TechsoMed and TransAlgae Israel Ltd.

Avi Hasson, Chief Scientist at the Israeli Ministry of Economy –responsible
for international activity in industrial R&D, said: "The current period in
which large Japanese companies are looking for new engines of growth through
innovation in business and technology can be a great window of opportunity
for Israeli companies in general and for startups in all fields of
technology in particular."

Noa Asher, Trade Representatives for the Israeli Ministry of Economy in
Japan, said: "The life sciences field is one of the target sectors of our
trade mission. Japan, which suffers negative population growth, invests 9.3%
of its GDP in its health system. The Japanese pharmaceuticals market is the
second-largest in the world and the Japanese government is acting vigorously
to revamp its health system."

Chief Scientist Avi Hasson will begin his visit to Japan on Tuesday July 28.
During his stay, he will hold a first-of-its-kind meeting with
representatives of METI where he will discuss cooperation between the two
countries, conduct a policy overview, discuss the innovation ecosystem of
both countries and plan future activities.

Additionally, the Chief Scientist will visit multinational Japanese
companies like Fujitsu, Panasonic, NTT and DNP. The Chief Scientist will
head a committee to approve the first seven projects submitted under the
R&D agreement's 1st Call for Proposals. Hasson will also visit Japan's
leading National Institute of Advanced Sciences and Technology (AIST) and
will address a recently installed Japanese governmental agency, the Council
for Science, Technology and Innovation (CSTI).

The Office of the Chief Scientist at the Israeli Ministry of Economy and
MATIMOP invite all companies interested in finding Japanese partners for
joint R&D or seeking funding for existing R&D partnerships to submit
applications for funding and support. A brief form available on the MATIMOP
website can be filled out to begin the process.

For more information, visit: www.matimop.org.il/japan.html